CMMB
Price
$1.51
Change
-$0.00 (-0.00%)
Updated
Oct 4 closing price
34 days until earnings call
CNTX
Price
$1.92
Change
-$0.06 (-3.03%)
Updated
Oct 4 closing price
33 days until earnings call
Ad is loading...

CMMB vs CNTX

Header iconCMMB vs CNTX Comparison
Open Charts CMMB vs CNTXBanner chart's image
Chemomab Therapeutics
Price$1.51
Change-$0.00 (-0.00%)
Volume$55.69K
CapitalizationN/A
Context Therapeutics
Price$1.92
Change-$0.06 (-3.03%)
Volume$1.19M
CapitalizationN/A
View a ticker or compare two or three
CMMB vs CNTX Comparison Chart
Loading...
CMMB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CNTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CMMB vs. CNTX commentary
Oct 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMMB is a Hold and CNTX is a Hold.

COMPARISON
Comparison
Oct 05, 2024
Stock price -- (CMMB: $1.51 vs. CNTX: $1.98)
Brand notoriety: CMMB and CNTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMMB: 20% vs. CNTX: 282%
Market capitalization -- CMMB: $22.54M vs. CNTX: $147.37M
CMMB [@Biotechnology] is valued at $22.54M. CNTX’s [@Biotechnology] market capitalization is $147.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMMB’s FA Score shows that 0 FA rating(s) are green whileCNTX’s FA Score has 1 green FA rating(s).

  • CMMB’s FA Score: 0 green, 5 red.
  • CNTX’s FA Score: 1 green, 4 red.
According to our system of comparison, CMMB is a better buy in the long-term than CNTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMMB’s TA Score shows that 4 TA indicator(s) are bullish while CNTX’s TA Score has 4 bullish TA indicator(s).

  • CMMB’s TA Score: 4 bullish, 5 bearish.
  • CNTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CMMB and CNTX are a bad buy in the short-term.

Price Growth

CMMB (@Biotechnology) experienced а -3.82% price change this week, while CNTX (@Biotechnology) price change was +7.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.51%. For the same industry, the average monthly price growth was +3.11%, and the average quarterly price growth was -5.53%.

Reported Earning Dates

CMMB is expected to report earnings on Nov 08, 2024.

CNTX is expected to report earnings on Nov 07, 2024.

Industries' Descriptions

@Biotechnology (+3.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTX($147M) has a higher market cap than CMMB($22.5M). CMMB YTD gains are higher at: 196.078 vs. CNTX (69.912). CMMB has higher annual earnings (EBITDA): -15.97M vs. CNTX (-20.01M). CNTX has more cash in the bank: 102M vs. CMMB (12.7M). CMMB (0) and CNTX (0) have equivalent revenues.
CMMBCNTXCMMB / CNTX
Capitalization22.5M147M15%
EBITDA-15.97M-20.01M80%
Gain YTD196.07869.912280%
P/E RatioN/AN/A-
Revenue00-
Total Cash12.7M102M12%
Total Debt360KN/A-
TECHNICAL ANALYSIS
Technical Analysis
CMMBCNTX
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 5 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
89%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CMMB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CNTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MNVRX31.150.28
+0.91%
Madison Investors R6
JSERX59.860.48
+0.81%
JPMorgan Small Cap Equity R5
CAABX26.230.19
+0.73%
ClearBridge Sustainability Leaders C
GQLVX14.380.09
+0.63%
Glenmede Quant US Large Cap Value Equity
TFOIX30.88N/A
N/A
Transamerica Capital Growth I

CMMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMMB has been loosely correlated with AXON. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CMMB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMMB
1D Price
Change %
CMMB100%
N/A
AXON - CMMB
37%
Loosely correlated
+1.63%
SPRB - CMMB
36%
Loosely correlated
+3.61%
DSGN - CMMB
30%
Poorly correlated
+5.93%
MDGL - CMMB
29%
Poorly correlated
+0.89%
OVID - CMMB
29%
Poorly correlated
+1.77%
More

CNTX and

Correlation & Price change

A.I.dvisor tells us that CNTX and FATE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTX and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
-3.03%
FATE - CNTX
30%
Poorly correlated
+3.21%
DSGN - CNTX
29%
Poorly correlated
+5.93%
CMMB - CNTX
29%
Poorly correlated
N/A
HRMY - CNTX
27%
Poorly correlated
-0.49%
TYRA - CNTX
25%
Poorly correlated
+2.13%
More